Dabrafenib in BRAF-mutated metastatic melanoma: a...

The Lancet 2012 Vol. 380; Iss. 9839

Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial

Axel Hauschild, Jean-Jacques Grob, Lev V Demidov, Thomas Jouary, Ralf Gutzmer, Michael Millward, Piotr Rutkowski, Christian U Blank, Wilson H Miller Jr, Eckhart Kaempgen, Salvador Martín-Algarra, Bogu
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
380
Year:
2012
Language:
english
DOI:
10.1016/s0140-6736(12)60868-x
File:
PDF, 258 KB
english, 2012
Conversion to is in progress
Conversion to is failed